(Q36200150)

12 August 2017

1 reference

title

Targeted drug delivery in cancer therapy (English)

1 reference

12 August 2017

1 reference

Jaspreet K Vasir

1

1 reference

12 August 2017

Vinod Labhasetwar

series ordinal

2

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Technology in Cancer Research and Treatment

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

363-374

1 reference

Delivery of molecular and cellular medicine to solid tumors

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Determining MDR1/P-glycoprotein expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Block copolymer micelles for delivery of gene and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Block copolymer micelles for drug delivery: design, characterization and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Determinants of drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Vascularization of tumors: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Engineering liposomes for drug delivery: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Combined cancer therapy by micellar-encapsulated drug and ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Ultrasound-triggered drug targeting of tumors in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Magnetically modulated therapeutic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Clinical applications of magnetic drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Iron oxide nanoparticles for sustained delivery of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Endoglin (CD105): a target for anti-angiogenetic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

21 January 2018

Targeting tumor cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Identification of tumour-associated T-cell epitopes for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Chemotherapy targeted to cancers through tumoral hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Expression profiling predicts outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

21 January 2018

Engineered antibodies

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Therapeutic cancer targeting peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Recombinant immunotoxins in targeted cancer cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Current methods for attaching targeting ligands to liposomes and nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Targeting of therapeutic agents to bone to treat metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

Doxorubicin in sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400405

10.1177/153303460500400405

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference